Cytacon 50microgram tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Cyanocobalamin

Available from:

Advanz Pharma

ATC code:

B03BA01

INN (International Name):

Cyanocobalamin

Dosage:

50microgram

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 09010200; GTIN: 0000050731893

Patient Information leaflet

CYTACON
®
50 MICROGRAMS
TABLETS
Cyanocobalamin
(Vitamin B
12
)
50 TABLETS
Peel here to read leaflet
but do not remove.
Tear along perforation
441.00 mm
54.00 mm
32.00 mm
m
m
0
0
.
1
5
m
m
0
0
.
1
5
m
m
0
0
.
1
5
m
m
0
0
.
1
5
m
m
0
0
.
1
5
m
m
0
0
.
2
5
Peel here to read leaflet
but do not remove.
B.No :
Exp :
Tear along perforation
The name of your medicine is Cytacon 50micrograms Tablets.
It will be referred to as Cytacon Tablets for ease of use hereafter.
WHAT IS IN THIS LEAFLET:
1. What Cytacon Tablets are and what they are used for
2. What you need to know before you take Cytacon Tablets
3. How to take Cytacon Tablets
4. Possible side effects
5. How to store Cytacon Tablets
6. Contents of the pack and other information
1. WHAT CYTACON TABLETS ARE AND WHAT THEY ARE USED FOR
Cytacon Tablets contain cyanocobalamin,which is known as vitamin B
12
.
Most people get enough vitamin B
12
from their food, but if you
have had stomach surgery, or certain diseases of the intestines, or
a restricted diet, you may not absorb enough vitamin B
12
.
Lack of vitamin B
12
in the body causes a disease called pernicious
anaemia (reduction in the number of red blood cells) which is
often treated with vitamin B
12
injections.
Cytacon tablets are used to treat vitamin B
12
deficiency when
injections cannot be used.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CYTACON TABLETS
DO NOT TAKE CYTACON TABLETS:
• if you are allergic to cyanocobalamin or any of the other
ingredients of this medicine (listed in section 6).
Those who have an allergic reaction to Cyanocobalamin by
injection are often able to take Cytacon Tablets without problems.
WARNINGS AND PRECAUTIONS:
Talk to your doctor or pharmacist before taking Cytacon Tablets
If you have any other medical conditions, speak to your doctor
before you take these tablets.
Your doctor will want to monitor your response to this medicine
carefully, particularly if you are young or elderly. This will
probably
involve regular examination of your blood every three months for
18 months and then an

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
_ _
Cytacon 50micrograms Tablets
Cyanocobalamin 50micrograms Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 50 micrograms Cyanocobalamin BP.
Excipient(s) with known effect
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Recommended Clinical Indications:
Treatment of nutritional Vitamin B
12
deficiency.
Treatment of vitamin B 12 deficiency following partial gastrectomy.
Treatment of tropical sprue, alone or with folic acid.
Treatment
of
pernicious
anaemia
when
parenteral
administration
is
not
possible or not advised.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Elderly:
The normal dose for adults is appropriate for the elderly.
Adults:
One to three tablets (50 to 150 micrograms) or more daily at the
discretion of the
physician.
In pernicious anaemia intramuscular therapy is preferable for initial
correction of
vitamin B12 deficiency. However, if necessary, the oral route may be
used to follow
this, in which case at least 300 micrograms should be given daily
Paediatric population:
One tablet (50 micrograms) daily at the discretion of the physician.
When possible,
This medicine
doses should be taken between meals.
Method of administration: Oral.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
Hypersensitivity to the product or any of the excipients.
4.4
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
For pernicious anaemia, an adequate dose must be used and the blood
picture
must be examined regularly at least every three months for 18 months
until
stabilised, and then annually.
Indiscriminate administration of this medicine may mask precise
diagnosis.
Patients with rare hereditary problems of galactose intolerance, total
lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.
4.5
INTERACTIONS
WITH
OTHER
MEDICINAL
PRODUCTS
AND
OTHER
FORMS
OF